Evidence map›Paper›PMID 42584608›Full record

ArticleJournal of the American Chemical Society2026

The Role of Terminal Heavy Chalcogenide Ligands in Enabling Hydride Transfer Reactivity of W═E (E = S, Se) Models for Molybdenum Hydroxylases.

Ananthu V Modappilappally, Neal P Mankad

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ananthu V ModappilappallyDepartment of Chemistry, University of Illinois Chicago, Chicago60607, Illinois, United States.
Neal P MankadDepartment of Chemistry, University of Illinois Chicago, Chicago60607, Illinois, United States.ORCID 0000-0001-6923-5164

Funding

Multimetallic Catalysis in Biology and SynthesisR35GM140850 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MANKAD, NEAL P · 2021 to 2025
$2.0M
National Institutes of Health (NIH) R35 GM140850NIGMS NIH HHS R35 GM140850
6 · The paper itself

Abstract

Whereas molybdenum-dependent hydroxylases in the xanthine oxidase family catalyze site-selective C-H hydroxylation reactions using terminal molybdenum sulfide (Mo═S) active sites, certain variants such as nicotinate dehydrogenase (NDH) replace the sulfide ligand by a selenide (Mo═Se) to enable activation of less reactive C-H bonds. To probe the origins of this dependence on terminal chalcogenide identity, we prepared and crystallographically characterized a synthetic model complex of the NDH active site, [(bdt)W(O)2Se]2-, a dioxotungsten(VI) selenide complex supported by benzene-1,2-dithiolate (bdt), for comparison to the previously reported [(bdt)W(O)3]2- and [(bdt)W(O)2S]2- analogues. Electronic structure analyses combining experimental UV-vis spectroscopy and DFT calculations indicate that replacement of terminal oxo ligands by heavier chalcogenides introduces accessible low-energy acceptor orbitals associated with more spatially distributed W═E (E = S, Se) interactions. Treatment of the terminal selenido and sulfido complexes with BH4- led to reduced tungsten products accompanied by liberation of free hydroselenide (HSe-) and hydrosulfide (HS-), respectively, whereas the corresponding trioxo analogue was unreactive under analogous conditions. These findings provide direct experimental support for the proposal that terminal heavy chalcogenide ligands play an active electronic role in enabling biological hydride-transfer reactivity in molybdenum hydroxylase enzymes.

Indexed as

ChalcogensMixed Function OxygenasesMolybdenumSeleniumTungstenCatalytic DomainLigandsModels, MolecularChalcogensLigandsMixed Function OxygenasesMolybdenumSeleniumTungsten

Identifiers

PMID42584608
PMCPMC13615484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.